NEW YORK (GenomeWeb News) – Horizon Discovery and the University of Washington said today that they have entered into a pair of additional licensing agreements in the area of human gene targeting.

The new agreements give Cambridge, UK-based Horizon the exclusive right to commercialize inventions made by UW researcher David Russell, relating to the use of parvoviral vectors in human genome engineering.

In exchange, UW will be granted an undisclosed number of shares in Horizon and will receive ongoing product royalties from licensed products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.